Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
SNDL Catalyst Timeline
Dated clinical, regulatory and corporate events for SNDL Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for SNDL Inc.
Upcoming catalysts 2
Event history 50
Past FDA Catalysts and PDUFA Decisions
How SNDL actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
SNDL Inc. is not a drug developer. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every SNDL program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| No insider trades match the selected filters. | |||||
Hedge Fund 13F Activity
Hedge Funds invested in SNDL
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in SNDL for Q3 2026. | ||||
Ownership Trends
SNDL Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How SNDL ranks across every disease it competes in
SNDL News
SNDL Reports Third Quarter 2026 Financial and Operational Results
SNDL Inc. reported its Q3 2026 results, showing a 2.5% decline in net revenue at $238.0 million. Despite a significant operating loss of $48.3 million, adjusted operating income returned to positive at $5.2 million. The company noted record free cash flow of $20.0 million and improvements in Cannabis Retail, though Cannabis Operations continued to struggle.
Read more →SNDL Announces 2026 Annual and Special Shareholders Meeting Results, Select Preliminary Third Quarter Results and Capital Return Initiatives
SNDL Inc. announced the results of its 2026 Annual and Special Meeting, where all five director nominees were elected. The company reported preliminary third quarter results, including a record free cash flow of approximately C$20 million. Shareholders also approved a share repurchase program, enhancing capital return initiatives.
Read more →SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026
SNDL Inc. announced it will release its third quarter 2026 financial results on October 27, 2026. The results will be available before market opening, followed by a conference call at 10:00 a.m. EDT. SNDL is a major player in the cannabis and liquor retail sectors in Canada.
Read more →SNDL Announces Resignation of Director
SNDL Inc. announced the immediate resignation of Carlo Cannell from its Board of Directors. The company expressed gratitude for his contributions. SNDL is recognized as a major player in the cannabis and liquor retail sectors in Canada, operating several retail brands and investing strategically in the industry.
Read more →SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility
SNDL Inc. announced the successful completion of a European Union Good Manufacturing Practice audit at its Atholville facility. This achievement enhances SNDL's ability to engage in international medical cannabis markets. The company expects to receive EU-GMP certification within 90 days, reinforcing its commitment to quality and operational excellence.
Read more →SNDL Reports Second Quarter 2026 Financial and Operational Results
SNDL reported a 3.7% revenue drop to $235.8 million in Q2 2026 due to market headwinds. Gross profit fell 16.6% to $56.3 million, driven by lower sales and Jeeter ramp-up costs. The company posted an operating loss of $7.8 million but improved free cash flow. SNDL also advanced its acquisition of Parallel's medical cannabis assets.
Read more →SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations
SNDL Inc. completed the acquisition of assets from Surterra Holdings, enhancing its position in the U.S. medical cannabis market. This transaction reduces Parallel's debt and provides SNDL with significant economic exposure. The company aims to convert this indirect stake into direct holdings, positioning itself for growth in states like Florida, Texas, and Massachusetts.
Read more →SNDL to Report Second Quarter 2026 Financial Results on July 28, 2026
SNDL Inc. will release its second quarter 2026 financial results on July 28, 2026. The results will be available before market opening. Following this, a conference call and webcast will occur at 10:00 a.m. EDT. SNDL is a leading cannabis and liquor retailer in Canada.
Read more →SNDL Announces Update on Arrangement Agreement with 1CM for Acquisition of Ontario Cannabis Stores
SNDL announced that its acquisition of Ontario cannabis stores from 1CM will not proceed due to prolonged regulatory reviews. The second closing, which involved acquiring 27 stores for $27.2 million, is not expected to happen before the May 31, 2026 deadline. However, SNDL has completed the first closing and will redirect funds towards share repurchases.
Read more →SNDL Reports First Quarter 2026 Financial and Operational Results
SNDL Inc. reported a net revenue of $195.9 million for Q1 2026, a 4.4% decrease from the previous year. The company faced challenges due to market softness in both liquor and cannabis segments, resulting in an operating loss of $9.1 million. Despite these setbacks, SNDL is implementing initiatives to enhance profitability and has a strong cash position.
Read more →SNDL Inc. Condensed Consolidated Interim Financial Statements For the three months ended
SNDL Inc. has released its condensed consolidated interim financial statements for the three months ended March 31, 2026. The company reported a decrease in net revenue and an increased operating loss compared to the same period last year. Additionally, the accumulation of shareholder equity showed only a slight improvement in the company's financial position. The overall performance reflects ongoing challenges in managing costs and generating revenue.
Read more →SNDL to Report First Quarter 2026 Financial Results on April 29, 2026
SNDL Inc. will release its first quarter 2026 financial results on April 29, 2026, before the market opens. A conference call and webcast will follow at 10:00 a.m. EDT the same day. The company is a leading cannabis retailer in Canada with a wide range of brands.
Read more →SNDL Inc. Condensed Consolidated Interim Financial Statements For the three and nine months ended
SNDL Inc. has released its condensed consolidated interim financial statements for the three and nine months ending September 30, 2025. The company reported a net revenue increase to CAD 693,902 for the nine-month period, with a gross profit of CAD 188,419. However, SNDL also noted a net loss attributable to its owners of CAD 25,141, reflecting ongoing challenges despite some increases in cash reserves and operating cash flow. Total assets decreased from CAD 1,349,242 to CAD 1,318,061, indicating potential financial strain.
Read more →SNDL Announces 2025 Annual and Special Meeting
SNDL Inc. held its Annual and Special Meeting of Shareholders where several key resolutions were approved. Shareholders fixed the number of directors at seven and elected all nominees with overwhelming support. The company also reappointed CBIZ Inc. as its auditors and approved its Stock Option Plan along with Restricted and Performance Share Unit Plan. These decisions reflect strong confidence among shareholders in the company's governance and future direction.
Read more →SNDL Reports Second Quarter 2025 Financial and Operational Results
SNDL Inc. reported its financial results for the second quarter of 2025, marking a pivotal milestone with positive operating income and net earnings for the first time. The company noted substantial growth across its business segments, particularly in cannabis, which outpaced the overall market growth. SNDL's liquor retail segment also showed resilience with sales growth despite fewer store locations. The company's strong financial position, highlighted by no debt and substantial cash reserves, positions it favorably for future opportunities.
Read more →SNDL Inc. Condensed Consolidated Interim Financial Statements For the three and six months ended
SNDL Inc. has released its condensed consolidated interim financial statements for the second quarter and first half of 2025. The company reported a net revenue increase to CAD 244,769 but also faced a net loss of CAD 11,822 for the first half of the year. Additionally, the company's accumulated deficit rose to CAD 1,299,404. Despite improvements in gross profit to CAD 67,601, the overall financial picture indicates significant challenges alongside some positive revenue growth.
Read more →SNDL to Announce Second Quarter 2025 Financial Results on July 31, 2025
SNDL Inc. has announced that it will release its second quarter 2025 financial results on July 31, 2025. The results are set to be disclosed before the market opens. Following the release, SNDL will host a conference call and webcast to discuss the results. The company operates as one of the largest vertically integrated cannabis companies in Canada and is a significant retailer in the liquor and cannabis sectors.
Read more →SNDL INC. NOTICE OF MEETING AND INFORMATION CIRCULAR DATED JUNE 20, 2025 FOR THE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD VIRTUALLY ON JULY 29, 2025 AT 10:00 a.m. (Toronto Time) SNDL INC. NOTICE OF ANNUAL AN
SNDL Inc. has announced that its annual and special meeting of shareholders will be held virtually on July 29, 2025, at 10:00 a.m. Toronto Time. The meeting will focus on several important matters including the election of directors and the approval of compensation plans. Shareholders are encouraged to participate and have been provided detailed information on how to attend and vote. The notice includes key details about the process of proxy voting and participation for registered and beneficial shareholders.
Read more →SNDL Reports First Quarter 2025 Financial and Operational Results
SNDL Inc. reported its financial and operational results for the first quarter of 2025, revealing a record gross margin and improvements in free cash flow. The company is in the process of acquiring 32 cannabis retail stores and launched a Rise Rewards loyalty program aimed at engaging customers more effectively. Despite these positive developments, SNDL faces operational losses and declines in the liquor retail segment, which may impact future performance. The Board has also initiated a strategic review regarding U.S. cannabis market operations and exchange listing options to enhance business growth.
Read more →